세계의 소화관 병원균 검사 시장 보고서(2025년)

Gastrointestinal Pathogen Testing Global Market Report 2025

US $ 4,490 ￦ 6,156,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 8,898,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,640,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

소화관 병원균 검사 시장 규모는 향후 수년간 안정적인 성장세를 보이며 2029년까지 연평균 4.3%의 성장률로 50억 1,000만 달러에 달할 것으로 예상됩니다. 예측 기간 중 성장의 배경에는 세계 소화기 감염증의 유행, 조기 발견 및 치료의 중요성에 대한 인식 증가, 신흥 경제국의 의료 인프라 확대, 현장 검사 솔루션에 대한 수요 증가, 식품 안전 규제에 대한 관심 증가, 지속적인 연구개발 노력 등이 있습니다. 예측 기간의 주요 동향으로는 신속 검사법, 분자진단 기술 채택 확대, 비 전통적인 의료 환경에서 현장 검사 확대, 검사 프로세스 간소화를 위한 자동화 및 로봇 공학의 발전, 병원체 검출을 강화하기 위한 새로운 바이오마커의 출현, 인공지능 및 머신러닝 알고리즘의 통합 등이 있습니다. 알고리즘의 통합 등이 있습니다.

식중독 증가로 인해 소화관 병원균 검사 시장은 당분간 확대될 전망입니다. 식중독은 리스테리아증, 바이러스성 위장염, 장티푸스, 선모충증과 같은 질병을 포함하여 유해한 미생물, 독소 또는 화학물질로 오염된 음식이나 음료의 섭취로 인한 질병을 포함합니다. 식중독의 급증은 식품 생산, 유통, 소비 관행의 변화, 불충분한 식품 안전 프로토콜, 기후 변화가 식품 생산에 미치는 영향 등 다양한 요인에 기인합니다. 위장 검사는 식중독을 유발하는 특정 병원체를 식별하고, 의료진이 위장 증상을 진단하고, 적절한 치료 방법을 결정하고, 발생을 모니터링하고, 식중독 확산을 완화하기 위한 예방 조치를 시행하는 데 매우 중요한 역할을 합니다. 예를 들어 2024년 2월 영국 보건안전청(UK Health Security Agency)의 데이터에 따르면 잉글랜드와 웨일즈에서 리스테리아증 사례가 증가하고 있으며, 2021년 160건에서 2022년 167건이 보고된 것으로 나타났습니다. 소화관 병원균 검사의 중요성이 높아지고 있음을 강조하고 있습니다.

소화관 병원균 검사 시장의 주요 기업은 소화관 병원균 검출의 정확성, 속도, 포괄성을 높이기 위해 메타유전체 진단 검사와 같은 최첨단 솔루션 개발에 주력하고 있습니다. 메타유전체 진단검사는 대변이나 혈액 등의 샘플에 존재하는 미생물의 유전물질을 분석하기 위해 활용되는 첨단 기술입니다. 예를 들어 호주에 본사를 둔 생명공학 기업 Microba Life Sciences는 2024년 4월, 광범위한 소화관 병원균을 전례 없는 정확도로 식별하기 위해 개발된 메타유전체 진단 테스트인 MetaPanel을 발표했습니다. 메타패널은 한 번의 검사로 175개의 병원체 타겟을 포괄하며, 일반적인 감염성 질환부터 까다로운 감염성 질환까지 진단할 수 있는 종합적인 툴을 의료진에게 제공합니다. 메타패널은 차세대 염기서열 분석(NGS) 기술을 활용하여 대변 샘플의 다양한 유전물질을 분석하여 기존 소화기 패널에서 일상적으로 평가되지 않았던 다양한 잠재적 병원균을 검출할 수 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스 및 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 소화관 병원균 검사 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 용도 산업의 분석
• 세계의 소화관 병원균 검사 시장 : 성장률 분석
• 세계의 소화관 병원균 검사 시장 실적 : 규모와 성장, 2019-2024
• 세계의 소화관 병원균 검사 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 소화관 병원균 검사 TAM(Total Addressable Market)

제6장 시장 세분화

• 세계의 소화관 병원균 검사 시장 : 병원체 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 세균
• 바이러스
• 기생충
• 세계의 소화관 병원균 검사 시장 : 테스트 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 분자 검사
• 문화
• 생화학 검사
• 기타 테스트 유형
• 세계의 소화관 병원균 검사 시장 : 패널 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 증후군 풀 멀티플렉스 패널
• 기타 패널 유형
• 세계의 소화관 병원균 검사 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 병원
• 진단 검사실
• POC(Point of Care)
• 기타 최종사용자
• 세계의 소화관 병원균 검사 시장 세균의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 살모넬라 속균
• 대장균
• 캄필로박터속
• 적리균속
• 클로스트리듐 디피실
• 비브리오속
• Listeria monocytogenes
• 헬리코박터 파일로리
• 기타 세균성 병원체
• 세계의 소화관 병원균 검사 시장 바이러스의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 노로바이러스
• 로타바이러스
• 장관 아데노바이러스
• A형 간염 바이러스(HAV)
• 아스트로 바이러스
• 기타 바이러스 병원체
• 세계의 소화관 병원균 검사 시장 기생충의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• Giardia lamblia
• Entamoeba histolytica
• Cryptosporidium spp.
• Trichinella spp.
• Toxoplasma gondii
• 기타 기생 병원체

제7장 지역별·국가별 분석

• 세계의 소화관 병원균 검사 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 소화관 병원균 검사 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 소화관 병원균 검사 시장 : 경쟁 구도
• 소화관 병원균 검사 시장 : 기업 개요
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 대기업과 혁신적 기업

• bioMerieux S.A.
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• DiaSorin S.p.A.
• Cepheid Inc.
• OraSure Technologies Inc.
• BioFire Diagnostics Inc.
• Luminex Corporation
• Meridian Bioscience Inc.
• Sekisui Diagnostics LLC
• ELITechGroup S.A.S.
• Hardy Diagnostics LLC
• Trinity Biotech plc
• Puritan Medical Products Co. LLC
• Cosmo Bio Co. Ltd.

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

• 소화관 병원균 검사 시장 2029 : 새로운 기회를 제공하는 국가
• 소화관 병원균 검사 시장 2029 : 새로운 기회를 제공하는 부문
• 소화관 병원균 검사 시장 2029 : 성장 전략
  • 시장 동향에 기반한 전략
  • 경쟁의 전략

제36장 부록

KSA

영문 목차

영문목차

Gastrointestinal pathogen testing refers to the diagnostic process aimed at identifying infections and diseases resulting from various pathogens affecting the digestive tract, which includes the stomach and intestines. This involves analyzing specimens such as stool or blood to identify the specific pathogens responsible for gastrointestinal symptoms, enabling accurate diagnosis and treatment of gastrointestinal disorders.

The primary types of pathogens targeted in gastrointestinal pathogen testing include bacteria, viruses, and parasites, all of which can cause illness in the digestive system. Various testing methods are employed, including molecular tests, culture techniques, biochemical assays, and others, with different panel types available, such as syndromic full multiplex panels and others. These testing services cater to a range of end-users, including hospitals, diagnostic laboratories, point-of-care facilities, and others.

The gastrointestinal pathogen testing market research report is one of a series of new reports from The Business Research Company that provides gastrointestinal pathogen testing market statistics, including gastrointestinal pathogen testing industry global market size, regional shares, competitors with a gastrointestinal pathogen testing market share, detailed gastrointestinal pathogen testing market segments, market trends and opportunities, and any further data you may need to thrive in the gastrointestinal pathogen testing industry. This gastrointestinal pathogen testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gastrointestinal pathogen testing market size has grown steadily in recent years. It will grow from $4.05 billion in 2024 to $4.24 billion in 2025 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to the increased prevalence of gastrointestinal infections, growth in awareness about foodborne illnesses, globalization leading to higher travel-related infections, regulatory initiatives for food safety, rise in healthcare expenditure, and heightened demand for rapid and accurate diagnostic solutions.

The gastrointestinal pathogen testing market size is expected to see steady growth in the next few years. It will grow to $5.01 billion in 2029 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to the increasing prevalence of gastrointestinal infections globally, growing awareness about the importance of early detection and treatment, expanding healthcare infrastructure in emerging economies, rising demand for point-of-care testing solutions, heightened focus on food safety regulations, and continuous research and development efforts. Major trends in the forecast period include rapid testing methods, growing adoption of molecular diagnostic techniques, expansion of point-of-care testing in non-traditional healthcare settings, advancements in automation and robotics for streamlined testing processes, the emergence of novel biomarkers for enhanced pathogen detection, and integration of artificial intelligence and machine learning algorithms.

The increasing occurrences of foodborne illnesses are poised to drive the expansion of the gastrointestinal pathogen testing market in the foreseeable future. Foodborne diseases encompass illnesses resulting from the consumption of food or beverages contaminated with harmful microorganisms, toxins, or chemical substances, including ailments such as listeriosis, viral gastroenteritis, taeniasis, and trichinosis. The upsurge in foodborne incidents can be attributed to various factors such as shifts in food production, distribution, and consumption practices, inadequate food safety protocols, and the impacts of climate change on food production. Gastrointestinal testing plays a crucial role in identifying the specific pathogens responsible for foodborne illnesses, aiding healthcare providers in diagnosing gastrointestinal symptoms, determining suitable treatment approaches, monitoring outbreaks, and implementing preventive measures to mitigate the spread of foodborne diseases. For instance, data from the UK Health Security Agency in February 2024 revealed an increase in listeriosis cases in England and Wales, with 167 reported cases in 2022 compared to 160 cases in 2021, underscoring the growing significance of gastrointestinal pathogen testing.

Key players in the gastrointestinal pathogen testing market are directing their efforts towards developing cutting-edge solutions, such as metagenomic diagnostic tests, to enhance the precision, speed, and comprehensiveness of gastrointestinal pathogen detection. Metagenomic diagnostic tests represent advanced technologies utilized for analyzing the genetic material of microorganisms present in samples such as stool or blood. For example, Microba Life Sciences, an Australia-based biotechnology company, introduced MetaPanel in April 2024-a metagenomic diagnostic test engineered to identify a broad spectrum of gastrointestinal pathogens with unprecedented accuracy. MetaPanel encompasses 175 pathogen targets within a single test, offering healthcare practitioners a comprehensive tool for diagnosing both common and challenging infections. Leveraging next-generation sequencing (NGS) technology, MetaPanel analyzes a diverse range of genetic material in stool samples, enabling the detection of various potential pathogens, including those not routinely assessed in traditional gastrointestinal panels.

In August 2022, SSI Diagnostica Group (SSID), a Denmark-based in-vitro diagnostics company, completed the acquisition of TechLab for an undisclosed sum. This acquisition is envisioned to broaden SSID's portfolio of infectious disease products and facilitate accelerated growth in the US market. The strategic move brings valuable commercial and manufacturing expertise, particularly in the pivotal US market. TechLab, based in the US, specializes in delivering rapid diagnostic tests for infectious diseases associated with the gastrointestinal and enteric systems.

Major companies operating in the gastrointestinal pathogen testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Becton Dickinson and Company, Hologic Inc., bioMerieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Cepheid Inc., OraSure Technologies Inc., BioFire Diagnostics Inc., Luminex Corporation, Meridian Bioscience Inc., Sekisui Diagnostics LLC, ELITechGroup S.A.S., Hardy Diagnostics LLC, Trinity Biotech plc, Puritan Medical Products Co. LLC, Cosmo Bio Co. Ltd., R-Biopharm AG, COPAN Diagnostics Inc., Savyon Diagnostics Ltd., ZeptoMetrix Corporation, Biomerica Inc., Pro-Lab Diagnostics

North America was the largest region in the gastrointestinal pathogen testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal pathogen testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gastrointestinal pathogen testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gastrointestinal pathogen testing market consists of revenues earned by entities by providing services, such as molecular testing, culture and sensitivity testing, and rapid diagnostics tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastrointestinal pathogen testing market also includes sales of testing kits, laboratory equipment, and PCR (Polymerase Chain Reaction) machines. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gastrointestinal Pathogen Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gastrointestinal pathogen testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gastrointestinal pathogen testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gastrointestinal pathogen testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Pathogen Type: Bacteria; Viruses; Parasites
• 2) By Test Type: Molecular Tests; Culture; Biochemical Tests; Other Test Types
• 3) By Panel Type: Syndromic Full Multiplex Panels; Other Panel Types
• 4) By End-User: Hospitals; Diagnostic Laboratories; Point-Of-Care; Other End Users
• Subsegments:
• 1) By Bacteria: Salmonella spp.; Escherichia coli; Campylobacter spp.; Shigella spp.; Clostridium difficile; Vibrio spp.; Listeria monocytogenes; Helicobacter pylori; Other Bacterial Pathogens
• 2) By Viruses: Norovirus; Rotavirus; Enteric Adenovirus; Hepatitis A Virus (HAV); Astrovirus; Other Viral Pathogens
• 3) By Parasites: Giardia lamblia; Entamoeba histolytica; Cryptosporidium spp.; Trichinella spp.; Toxoplasma gondii; Other Parasitic Pathogens
• Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; F. Hoffmann-La Roche Ltd; Becton Dickinson and Company; Hologic Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gastrointestinal Pathogen Testing Market Characteristics

3. Gastrointestinal Pathogen Testing Market Trends And Strategies

4. Gastrointestinal Pathogen Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Gastrointestinal Pathogen Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Gastrointestinal Pathogen Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Gastrointestinal Pathogen Testing Market Growth Rate Analysis
• 5.4. Global Gastrointestinal Pathogen Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Gastrointestinal Pathogen Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Gastrointestinal Pathogen Testing Total Addressable Market (TAM)

6. Gastrointestinal Pathogen Testing Market Segmentation

• 6.1. Global Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bacteria
• Viruses
• Parasites
• 6.2. Global Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Molecular Tests
• Culture
• Biochemical Tests
• Other Test Types
• 6.3. Global Gastrointestinal Pathogen Testing Market, Segmentation By Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Syndromic Full Multiplex Panels
• Other Panel Types
• 6.4. Global Gastrointestinal Pathogen Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Laboratories
• Point-Of-Care
• Other End Users
• 6.5. Global Gastrointestinal Pathogen Testing Market, Sub-Segmentation Of Bacteria, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Salmonella spp.
• Escherichia coli
• Campylobacter spp.
• Shigella spp.
• Clostridium difficile
• Vibrio spp.
• Listeria monocytogenes
• Helicobacter pylori
• Other Bacterial Pathogens
• 6.6. Global Gastrointestinal Pathogen Testing Market, Sub-Segmentation Of Viruses, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Norovirus
• Rotavirus
• Enteric Adenovirus
• Hepatitis A Virus (HAV)
• Astrovirus
• Other Viral Pathogens
• 6.7. Global Gastrointestinal Pathogen Testing Market, Sub-Segmentation Of Parasites, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Giardia lamblia
• Entamoeba histolytica
• Cryptosporidium spp.
• Trichinella spp.
• Toxoplasma gondii
• Other Parasitic Pathogens

7. Gastrointestinal Pathogen Testing Market Regional And Country Analysis

• 7.1. Global Gastrointestinal Pathogen Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Gastrointestinal Pathogen Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gastrointestinal Pathogen Testing Market

• 8.1. Asia-Pacific Gastrointestinal Pathogen Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Gastrointestinal Pathogen Testing Market, Segmentation By Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gastrointestinal Pathogen Testing Market

• 9.1. China Gastrointestinal Pathogen Testing Market Overview
• 9.2. China Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Gastrointestinal Pathogen Testing Market, Segmentation By Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gastrointestinal Pathogen Testing Market

• 10.1. India Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Gastrointestinal Pathogen Testing Market, Segmentation By Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gastrointestinal Pathogen Testing Market

• 11.1. Japan Gastrointestinal Pathogen Testing Market Overview
• 11.2. Japan Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Gastrointestinal Pathogen Testing Market, Segmentation By Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gastrointestinal Pathogen Testing Market

• 12.1. Australia Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Gastrointestinal Pathogen Testing Market, Segmentation By Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gastrointestinal Pathogen Testing Market

• 13.1. Indonesia Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Gastrointestinal Pathogen Testing Market, Segmentation By Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gastrointestinal Pathogen Testing Market

• 14.1. South Korea Gastrointestinal Pathogen Testing Market Overview
• 14.2. South Korea Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Gastrointestinal Pathogen Testing Market, Segmentation By Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gastrointestinal Pathogen Testing Market

• 15.1. Western Europe Gastrointestinal Pathogen Testing Market Overview
• 15.2. Western Europe Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Gastrointestinal Pathogen Testing Market, Segmentation By Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gastrointestinal Pathogen Testing Market

• 16.1. UK Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Gastrointestinal Pathogen Testing Market, Segmentation By Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gastrointestinal Pathogen Testing Market

• 17.1. Germany Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Gastrointestinal Pathogen Testing Market, Segmentation By Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gastrointestinal Pathogen Testing Market

• 18.1. France Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Gastrointestinal Pathogen Testing Market, Segmentation By Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gastrointestinal Pathogen Testing Market

• 19.1. Italy Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Gastrointestinal Pathogen Testing Market, Segmentation By Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gastrointestinal Pathogen Testing Market

• 20.1. Spain Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Gastrointestinal Pathogen Testing Market, Segmentation By Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gastrointestinal Pathogen Testing Market

• 21.1. Eastern Europe Gastrointestinal Pathogen Testing Market Overview
• 21.2. Eastern Europe Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Gastrointestinal Pathogen Testing Market, Segmentation By Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gastrointestinal Pathogen Testing Market

• 22.1. Russia Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Gastrointestinal Pathogen Testing Market, Segmentation By Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gastrointestinal Pathogen Testing Market

• 23.1. North America Gastrointestinal Pathogen Testing Market Overview
• 23.2. North America Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Gastrointestinal Pathogen Testing Market, Segmentation By Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gastrointestinal Pathogen Testing Market

• 24.1. USA Gastrointestinal Pathogen Testing Market Overview
• 24.2. USA Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Gastrointestinal Pathogen Testing Market, Segmentation By Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gastrointestinal Pathogen Testing Market

• 25.1. Canada Gastrointestinal Pathogen Testing Market Overview
• 25.2. Canada Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Gastrointestinal Pathogen Testing Market, Segmentation By Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gastrointestinal Pathogen Testing Market

• 26.1. South America Gastrointestinal Pathogen Testing Market Overview
• 26.2. South America Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Gastrointestinal Pathogen Testing Market, Segmentation By Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gastrointestinal Pathogen Testing Market

• 27.1. Brazil Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Gastrointestinal Pathogen Testing Market, Segmentation By Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gastrointestinal Pathogen Testing Market

• 28.1. Middle East Gastrointestinal Pathogen Testing Market Overview
• 28.2. Middle East Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Gastrointestinal Pathogen Testing Market, Segmentation By Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gastrointestinal Pathogen Testing Market

• 29.1. Africa Gastrointestinal Pathogen Testing Market Overview
• 29.2. Africa Gastrointestinal Pathogen Testing Market, Segmentation By Pathogen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Gastrointestinal Pathogen Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Gastrointestinal Pathogen Testing Market, Segmentation By Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gastrointestinal Pathogen Testing Market Competitive Landscape And Company Profiles

• 30.1. Gastrointestinal Pathogen Testing Market Competitive Landscape
• 30.2. Gastrointestinal Pathogen Testing Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Gastrointestinal Pathogen Testing Market Other Major And Innovative Companies

• 31.1. bioMerieux S.A.
• 31.2. Bio-Rad Laboratories Inc.
• 31.3. QIAGEN N.V.
• 31.4. DiaSorin S.p.A.
• 31.5. Cepheid Inc.
• 31.6. OraSure Technologies Inc.
• 31.7. BioFire Diagnostics Inc.
• 31.8. Luminex Corporation
• 31.9. Meridian Bioscience Inc.
• 31.10. Sekisui Diagnostics LLC
• 31.11. ELITechGroup S.A.S.
• 31.12. Hardy Diagnostics LLC
• 31.13. Trinity Biotech plc
• 31.14. Puritan Medical Products Co. LLC
• 31.15. Cosmo Bio Co. Ltd.

32. Global Gastrointestinal Pathogen Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gastrointestinal Pathogen Testing Market

34. Recent Developments In The Gastrointestinal Pathogen Testing Market

35. Gastrointestinal Pathogen Testing Market High Potential Countries, Segments and Strategies

• 35.1 Gastrointestinal Pathogen Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Gastrointestinal Pathogen Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Gastrointestinal Pathogen Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료